Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Kala Bio signs LOI to buy nationwide telehealth platform for about $15 million

Kala Bio signs LOI to buy nationwide telehealth platform for about $15 million

BitgetBitget2026/09/29 11:33
  • Kala Bio signed a non-binding LOI to buy a privately held MSO supporting a 50-state telehealth platform.
  • Transaction valued at about 15 million, payable in cash and Kala stock; cash portion expected from existing balance sheet resources.
  • Target posted USD 12.7 million trailing-12-month revenue ended August 2026; management described the business as cash-flow positive.
  • Platform has served more than 90,000 clients since 2023; more than USD 48 million in sales since inception.
  • Due diligence set for 45 days, expected to end in November 2026; closing targeted for late 2026 or early 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kala Bio Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609290730NEWSFILECNPR____20260929_316479_1) on September 29, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ - Australian winemaker Treasury Wine recovers early losses, Jefferies believes its troubles in the US are easing

October 7th - Treasury Wine Estates (TWE.AX) shares recovered a 1.8% loss in afternoon trading and were basically flat. Jefferies maintained a "Hold" rating on TWE and an AUD 6 target price, stating that although excess inventory and rising costs in the US market are limiting upside potential, TWE’s underperformance relative to the broader market has been narrowing. The brokerage expects a 1.2% increase in EBIT for fiscal year 2027 and notes that the US wine market is showing moderate growth in the higher price segment. Jefferies mentioned that the price segment below $20 still faces significant challenges and emphasized that low-priced wines continue to face pressure. The brokerage pointed out that competitor Constellation Brands’ (STZ.N) wine and spirits business saw organic sales increase by 17.2% in the second quarter, with sales to retailers up by 10.2%. TWE shares have risen 6.1% year-to-date. (For the convenience of non-English speakers, Reuters offers automated translations of its report into a number of other languages. Automated translation may contain errors or may not capture the intended context, and Reuters does not guarantee the accuracy of this text. It is provided only for convenience, and Reuters is not liable for any damage or loss caused by the use of automated translation.)

路透社•2026/10/07 04:16
BUZZ - Australian winemaker Treasury Wine recovers early losses, Jefferies believes its troubles in the US are easing